MedTrace Logo

Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients

NCT01278693 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2011-01-19

No results posted yet for this study

Summary

The purpose of this study is to determine Effect of oral L-carnitine supplement on lipid profile, anemia, and quality of life.

Conditions

  • Complication of Hemodialysis

Interventions

DRUG

L-carnitine

500 mg,twice daily, 16 weeks

DRUG

placebo

500 mg,twice daily, 16 weeks.

Sponsors & Collaborators

  • Isfahan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mahnaz Moradi, MD · MD,research comittee

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01278693 on ClinicalTrials.gov